RNXT Graph | RENOVORX, INC.

RNXT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

2026-06-30: Revenue $909.00K; Cost of revenue $143.00K; Research and development $1.20M; Selling, general and administrative $2.92M.
2026-03-31: Revenue $563.00K; Cost of revenue $84.00K; Research and development $1.23M; Selling, general and administrative $2.72M.
2025-12-31: Revenue $238.00K*; Cost of revenue $28.00K*; Research and development $1.50M*; Selling, general and administrative $2.23M*.
2025-09-30: Revenue $266.00K; Cost of revenue $53.00K; Research and development $1.69M; Selling, general and administrative $1.73M.

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Income tax	Net income
2026-06-30	$909.00K	$143.00K	$1.20M	$2.92M	$4.12M	(m)	-$2.91M
2026-03-31	$563.00K	$84.00K	$1.23M	$2.72M	$3.95M	$0.00	-$3.52M
2025-12-31	$238.00K*	$28.00K*	$1.50M*	$2.23M*	$3.73M*	$2.00K*	-$2.94M*
2025-09-30	$266.00K	$53.00K	$1.69M	$1.73M	$3.41M	(m)	-$2.91M
2025-06-30	$422.00K	$152.00K	$1.43M	$1.52M	$2.95M	(m)	-$2.90M
2025-03-31	$197.00K	$94.00K	$1.64M	$1.57M	$3.21M	$0.00	-$2.42M
2024-09-30	(m)	(m)	$1.65M	$1.18M	$2.83M	(m)	-$2.47M
2024-06-30	(m)	(m)	$1.54M	$1.49M	$3.03M	(m)	-$2.39M
2024-03-31	(m)	(m)	$1.26M	$1.22M	$2.48M	$0.00	-$1.08M
2023-09-30	(m)	(m)	$1.63M	(m)	$2.98M	(m)	-$1.42M
2023-06-30	(m)	(m)	$1.93M	(m)	$3.38M	(m)	-$2.33M
2023-03-31	(m)	(m)	$1.34M	(m)	$3.26M	(m)	-$3.26M
2022-09-30	(m)	(m)	$846.00K	(m)	$2.16M	(m)	-$2.14M
2022-06-30	(m)	(m)	$1.39M	(m)	$2.61M	(m)	-$2.59M
2022-03-31	(m)	(m)	$1.29M	(m)	$3.00M	(m)	-$3.00M
2021-09-30	(m)	(m)	$767.00K	(m)	$1.40M	(m)	-$1.51M
2021-06-30	(m)	(m)	$536.00K	(m)	$866.00K	(m)	-$1.31M
2021-03-31	(m)	(m)	$635.00K	(m)	$1.05M	(m)	-$1.15M
2020-09-30	(m)	(m)	$727.00K	(m)	$910.00K	(m)	-$1.10M
2020-06-30	(m)	(m)	(m)	(m)	(m)	(m)	-$773.00K
2020-03-31	(m)	(m)	(m)	(m)	(m)	(m)	-$1.05M

Revenue and expense 6 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Income tax	Net income
2026-06-30	$1.47M	$227.00K	$2.43M	$5.63M	$8.06M	$0.00	-$6.43M
2025-06-30	$619.00K	$246.00K	$3.07M	$3.09M	$6.16M	$0.00	-$5.32M
2024-06-30	(m)	(m)	$2.80M	$2.71M	$5.51M	$0.00	-$3.46M
2023-06-30	(m)	(m)	$3.26M	(m)	$6.64M	(m)	-$5.58M
2022-06-30	(m)	(m)	$2.68M	(m)	$5.62M	(m)	-$5.60M
2021-06-30	(m)	(m)	$1.17M	(m)	$1.92M	(m)	-$2.46M

Revenue and expense 9 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Income tax	Net income
2025-09-30	$885.00K	$299.00K	$4.77M	$4.81M	$9.57M	$0.00	-$8.23M
2024-09-30	(m)	(m)	$4.45M	$3.89M	$8.34M	$0.00	-$5.94M
2023-09-30	(m)	(m)	$4.89M	(m)	$9.62M	(m)	-$7.00M
2022-09-30	(m)	(m)	$3.52M	(m)	$7.78M	(m)	-$7.73M
2021-09-30	(m)	(m)	$1.94M	(m)	$3.31M	(m)	-$3.97M
2020-09-30	(m)	(m)	$1.93M	(m)	$2.56M	(m)	-$2.92M

Revenue and expense 12 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Income tax	Net income
2025-12-31	$1.12M	$327.00K	$6.27M	$7.04M	$13.31M	$2.00K	-$11.17M
2024-12-31	$43.00K	$0.00	$6.03M	$4.99M	$11.01M	(m)	-$8.81M
2023-12-31	(m)	(m)	$5.67M	$5.73M	$11.40M	(m)	-$10.23M
2022-12-31	(m)	(m)	$4.30M	(m)	$9.95M	(m)	-$9.89M
2021-12-31	(m)	(m)	$3.04M	(m)	$5.67M	(m)	-$6.32M
2020-12-31	(m)	(m)	$2.39M	(m)	$3.20M	(m)	-$3.80M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
FRACTYL HEALTH, INC. (GUTS)	United States	$0.075B	-1.18
Pulmonx Corp (LUNG)	United States	$0.082B	-1.16
CVRx, Inc. (CVRX)	United States	$0.067B	-2.62
SkinHealth Systems Inc. (SKIN)	United States	$0.086B	-3.17
DarioHealth Corp. (DRIO)		$0.066B	-1.39
LENSAR, Inc. (LNSR)	United States	$0.087B	2.02
Microbot Medical Inc. (MBOT)		$0.089B	-7.97
TELA Bio, Inc. (TELA)	United States	$0.057B	-0.82
Xtant Medical Holdings, Inc. (XTNT)	United States	$0.053B
Spectral AI, Inc. (MDAI)	United States	$0.052B